ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,182.96
-0.85%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,421.295
0.54%
Brent Oil
84.315
-0.33%
Bitcoin
63,695.23
4.79%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
15/07/202415:25RNS Regulatory NewsGlazer Capital, LLC Form 8.3 - Global Ports Holding plcLSE:GPHGlobal Ports Holding Plc
15/07/202415:25RNS Regulatory NewsMaven Investment Partners Ltd Form 8.3 - QUANEX BUILDING PRODUCTS CORPTTMQuanex Building Products Corp
15/07/202415:25RNS Regulatory NewsUBS O'Connor Form 8.3 - Smith (DS) PlcLSE:SMDSSmith (ds) Plc
15/07/202415:25RNS Regulatory NewsGlazer Capital, LLC Form 8.3 - Alpha Financial Markets Consulting plcLSE:AFMAlpha Financial Markets Consulting Plc
15/07/202415:25RNS Regulatory NewsGlazer Capital, LLC Form 8.3 - Mattioli Woods plcLSE:MTWMattioli Woods Plc
15/07/202415:25RNS Regulatory NewsGlazer Capital, LLC Form 8.3 - Keywords Studios plcLSE:KWSKeywords Studios Plc
15/07/202415:25PR Newswire (US)Active Pharmaceutical Ingredients (API) Market to Surpass USD 351.81 Billion Valuation by 2031, High Demand for Effective Therapeutics and Drugs Driving Market Development | SkyQuest Technology
15/07/202415:25PR Newswire (US)Active Pharmaceutical Ingredients (API) Market to Surpass USD 351.81 Billion Valuation by 2031, High Demand for Effective Therapeutics and Drugs Driving Market Development | SkyQuest Technology
15/07/202415:24EQS Regulatory NewsHoldings in CompanyLSE:MGCIM&g Credit Income Investment Trust Plc
15/07/202415:24RNS Regulatory NewsBarclays PLC Form 8.3 - International Paper CompanyLSE:BARCBarclays Plc
15/07/202415:24RNS Regulatory NewsBarclays PLC Form 8.3 - International Paper CompanyLSE:0JCBInternational Paper Co
15/07/202415:24RNS Regulatory NewsFIL Limited Form 8.3 - QUANEX BUILDING PRODUCTS CORPORATIONLSE:TYMNTyman Plc
15/07/202415:24RNS Regulatory NewsFIL Limited Form 8.3 - QUANEX BUILDING PRODUCTS CORPORATIONTTMQuanex Building Products Corp
15/07/202415:24PR Newswire (US)Mobile Value-Added Services (MVAS) Market size is set to grow by USD 1.00 trillion from 2024-2028, Rapid increase in smartphone penetration to boost the market growth, Technavio
15/07/202415:23RNS Regulatory NewsBarclays PLC Form 8.3 - Hipgnosis Songs Fund LimitedLSE:SONGHipgnosis Songs Fund Limited
15/07/202415:23RNS Regulatory NewsBarclays PLC Form 8.3 - Hipgnosis Songs Fund LimitedLSE:BARCBarclays Plc
15/07/202415:23PR Newswire (US)Stevia Market to Reach a Valuation of US$ 739.4 Million by 2034 Amid Growing Demand for Sugar Alternatives Worldwide | Future Market Insights, Inc.
15/07/202415:22UK RegulatoryMajor shareholder announcement - Pharma Equity Group A/SLSE:0REUPharma Equity Group A/s
15/07/202415:20RNS Regulatory NewsBarclays PLC Form 8.3 - Smith (DS) plcLSE:SMDSSmith (ds) Plc
15/07/202415:20RNS Regulatory NewsBarclays PLC Form 8.3 - Smith (DS) plcLSE:BARCBarclays Plc
15/07/202415:20RNS Regulatory NewsBlackRock Group Form 8.3 - Redrow plcLSE:RDWRedrow Plc
15/07/202415:20RNS Regulatory NewsBlackRock Group Form 8.3 - Virgin Money UK plcLSE:VMUKVirgin Money Uk Plc
15/07/202415:20RNS Regulatory NewsBlackRock Group Form 8.3 - Wood Group (John) plcLSE:WG.Wood Group (john) Plc
15/07/202415:20RNS Regulatory NewsBlackRock Group Form 8.3 - NewRiver REIT plcLSE:NRRNewriver Reit Plc
15/07/202415:20RNS Regulatory NewsBlackRock Group Form 8.3 - Tyman plcLSE:TYMNTyman Plc
15/07/202415:20RNS Regulatory NewsBlackRock Group Form 8.3 - Smith (DS) plcLSE:SMDSSmith (ds) Plc
15/07/202415:20RNS Regulatory NewsBlackRock Group Form 8.3 - Keywords Studios plcLSE:KWSKeywords Studios Plc
15/07/202415:20RNS Regulatory NewsBlackRock Group Form 8.3 - Quanex Building Products CorporationTTMQuanex Building Products Corp
15/07/202415:20RNS Regulatory NewsBlackRock Group Form 8.3 - Spirent Communications plcLSE:SPTSpirent Communications Plc
15/07/202415:20RNS Regulatory NewsBlackRock Group Form 8.3 - Network International Holdings plcLSE:NETWNetwork International Holdings Plc

Your Recent History

LSE
GDR
Genedrive
LSE
VAST
Vast Resources
LSE
SBTX
Skinbiotherapeutics
LSE
SOLG
Solgold
LSE
ENET
Ethernity Networks
LSE
AAZ
Anglo Asian Mining
LSE
LLOY
Lloyds Banking
LSE
ALTN
Altyngold
LSE
CASP
Caspian Sunrise
LSE
QBT
Quantum Blockchain Techn...
LSE
GKP
Gulf Keystone Petroleum
LSE
ZED
Zenova
LSE
GSF
Gore Street Energy Storage
LSE
CPX
Cap-xx
LSE
POS
Plexus
LSE
OPTI
Optibiotix Health
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved